openPR Logo
Press release

Metabolomics Market is growing with double digit CAGR of 13.2% upto 2023 | Top 3 Key players are Agilent Technologies, Danaher Corporation, Biocrates Life Sciences AG

06-19-2019 08:45 PM CET | Health & Medicine

Press release from: Allied Market Research

Metabolomics Market

Metabolomics Market

The Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023. North America contributed the highest market share in 2017; while, Asia-Pacific is expected to experience the highest growth rate during the forecast period.

Download the Sample Report @ http://bit.ly/2L0wt8E

The report offers insights on drivers, restraints, and opportunities of the global metabolomics market. Surge in adoption of metabolomics in precision medicine and rise in R&D investments are expected to facilitate the market growth. In addition, technological advancements for auxiliary medical devices utilized for analysis of metabolomics and rise in demand of quality medications supplements the growth of the market. However, expensive medical devices and lack of effective data management for profiling of metabolomics restrain the market growth.

The report provides an extensive analysis of the global metabolomics market based on product & service, application, indication, and geography. Based on product & service, the report segments the market into metabolomics instruments and metabolomics bioinformatics tools & services. The application segment is further classified into biomarker discovery, toxicology testing, drug discovery, functional genomics, nutrigenomics, personalized medicine, and others. Based on indication, the report bifurcates the market into cancer, neurological disorders, cardiovascular disorders, inborn errors of metabolism, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The biomarker discovery segment contributed the highest market share in 2017, and will maintain its dominant share during the forecast period. Advancements in quantification methods & technologies along with rise in concerns regarding prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer would fuel the growth of this segment.

For More Inquiry @ http://bit.ly/2WWjw24

Key Findings of the report:
• The drug discovery segment is anticipated to witness the highest grow rate during the forecast period.
• The biomarker discovery segment generated the highest market share in 2017 and is expected to maintain its dominance in the during the forecast period.
• North America dominated the global metabolomics market in 2017.
• China would register the highest CAGR in the Asia-Pacific region.

North America held the major market share in 2017, owing to surge in R&D investments and availability of advanced healthcare facilities. In addition, rise in usage of experimental medicines and increase in adoption of metabolomics for precision medicine fuel the growth. However, Asia-pacific would grow at the highest CAGR during the forecast period owing to increase in adoption of metabolomics in medical research and increase in government initiatives for finding cost-effective treatments for chronic diseases.

The key companies analyzed in the report include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation, Bruker Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc., Shimadzu Corporation, Bio-Rad Laboratories, Inc., Waters Corporation, and Thermo Fisher Scientific Inc.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolomics Market is growing with double digit CAGR of 13.2% upto 2023 | Top 3 Key players are Agilent Technologies, Danaher Corporation, Biocrates Life Sciences AG here

News-ID: 1781637 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Metabolomics

Emerging Trends Influencing The Growth Of The Metabolomics Services Market: Inno …
The Metabolomics Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Metabolomics Services Market Size Expected to Be by 2034? The metabolomics services market size will grow from $2.65 billion in 2024 to $3.04 billion in 2025 at a compound annual growth
Major Market Shift in Metabolomics Services Industry: Innovative Diagnostic Tool …
"What Is the Forecasted Market Size and Growth Rate for the Metabolomics Services Market? The scale of the metabolomics services market has rapidly expanded in the last few years. It is projected to surge from $2.65 $ billion in 2024 to $3.04 $ billion in 2025, representing a compound annual growth rate (CAGR) of 14.7%. This growth during the historical span is the result of a greater emphasis on biomarker discovery,
Coverage: Metabolomics Market covers analysis By Products and Services (Metabolo …
Metabolomics is the study of small molecules which resides in cells, biofluids, and tissues. The studies are extensively conducted with an aim to analyze biochemical activities of these small molecules and their interactions with biological systems. Metabolomics has wide variety of applications in disease diagnosis, drug discovery, enzyme discovery, and others. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00008670?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Thermo Fisher Scientific Inc. Waters Corporation Agilent Technologies, Inc. Human Metabolome Technologies, Inc. Bruker Corporation Shimadzu Corporation PerkinElmer Metabolon, Inc. Leco Corporation Hitachi
Metabolomics Market: Partnerships and investments to speed up development of met …
In the field of precision medicine, metabolomics has been playing a crucial part and emerging as a vital tool. The analysis of metabolites such as amino acids, sugars, and lipids within biological systems can be utilized for diagnosing various types of diseases such as cancer, depression, and others. Market players have adopted various strategies such as partnership and raising funding to accelerate the development of products. Request Sample Report at:
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024. Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules